OPR - Delayed Quote • USD BMRN May 2024 90.000 call (BMRN240517C00090000) Follow 0.2000 -0.2000 (-50.00%) At close: April 26 at 3:05 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for BMRN240517C00090000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: BMRN Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN) BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations Pfizer hemophilia gene therapy arrives in US to uncertain future BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales BioMarin drops drug programs in pipeline cull Q1 2024 Biomarin Pharmaceutical Inc Earnings Call Biomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ... BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates BioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimates BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates BioMarin Reports Record Financial Results for the First Quarter 2024
